Abstract
Due to the worldwide increase in allergies and a limited efficacy of therapeutic interventions, the need for prophylactic vaccination against allergies has been recognized. mRNA and DNA vaccines have demonstrated their high potential for preventing allergic sensitization by inducing an immunological bias that prevents TH2 sensitization. However, only mRNA vaccines fulfill the stringent safety requirements for vaccination of healthy children. In this chapter, we describe the generation of conventional as well as self-replicating mRNA vaccines and methods to test their prophylactic efficacy in animal models.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Weiner L, Mackler B, Hearl B et al. (2013) Poster 2011: a DNA vaccine immunotherapy for japanese red cedar allergy. Paper presented at the WAO Symposium on Immunotherapy and Biologics, Chicago, Feb 2014
Weiss R, Scheiblhofer S, Roesler E et al (2012) mRNA vaccination as a safe approach for specific protection from type I allergy. Expert Rev Vaccines 11:55–67
Weiss R, Scheiblhofer S, Roesler E et al (2010) Prophylactic mRNA vaccination against allergy. Curr Opin Allergy Clin Immunol 10:567–574
Weiss R, Scheiblhofer S, Thalhamer J (2014) Allergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseases. Hum Vaccin Immunother 10:703–707
Hattinger E, Scheiblhofer S, Roesler E et al (2015) Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice. J Immunol Res 2015:797421. doi:10.1155/2015/797421
Scheiblhofer S, Weiss R, Gabler M et al (2006) Replicase-based DNA vaccines for allergy treatment. Methods Mol Med 127:221–235
Isakovic A, Weiss R, Thalhamer J et al (2014) Protective and therapeutic DNA vaccination against allergic diseases. Methods Mol Biol 1143:243–258
Schlake T, Thess A, Fotin-Mleczek M et al (2012) Developing mRNA-vaccine technologies. RNA Biol 9:1319–1330
Holtkamp S, Kreiter S, Selmi A et al (2006) Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108:4009–4017
Annweiler A, Hipskind RA, Wirth T (1991) A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res 19:3750
Levis R, Schlesinger S, Huang HV (1990) Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol 64:1726–1733
Ou JH, Strauss EG, Strauss JH (1981) Comparative studies of the 3'-terminal sequences of several alpha virus RNAs. Virology 109:281–289
Frolov I, Hardy R, Rice CM (2001) Cis-acting RNA elements at the 5' end of Sindbis virus genome RNA regulate minus- and plus-strand RNA synthesis. RNA 7:1638–1651
Gabler M, Scheiblhofer S, Kern K et al (2006) Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 118:734–741
Gurevich VV, Pokrovskaya ID, Obukhova TA et al (1991) Preparative in vitro mRNA synthesis using SP6 and T7 RNA polymerases. Anal Biochem 195:207–213
Cunningham PR, Ofengand J (1990) Use of inorganic pyrophosphatase to improve the yield of in vitro transcription reactions catalyzed by T7 RNA polymerase. Biotechniques 9:713–714
Kuhn AN, Diken M, Kreiter S et al (2010) Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther 17:961–971
Guo PX, Moss B (1990) Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli. Proc Natl Acad Sci U S A 87:4023–4027
Probst J, Weide B, Scheel B et al (2007) Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther 14:1175–1180
McKenna SA, Kim I, Puglisi EV et al (2007) Purification and characterization of transcribed RNAs using gel filtration chromatography. Nat Protoc 2:3270–3277
Roesler E, Weiss R, Weinberger EE et al (2009) Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. J Allergy Clin Immunol 124:1070–1077
Barsumian EL, Isersky C, Petrino MG et al (1981) IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol 11:317–323
Acknowledgements
This work was supported by the Austrian Science Fund, grant # W1213.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Weiss, R., Scheiblhofer, S., Thalhamer, J. (2017). Generation and Evaluation of Prophylactic mRNA Vaccines Against Allergy. In: Kramps, T., Elbers, K. (eds) RNA Vaccines. Methods in Molecular Biology, vol 1499. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6481-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6481-9_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6479-6
Online ISBN: 978-1-4939-6481-9
eBook Packages: Springer Protocols